John A. Colwell

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Cholesterol determination in high-density lipoproteins separated by three different methods.

Maria F. Lopes‐Virella, Pam Stone, Stephen G. Ellis et al. · Clinical Chemistry · 1977 · 1.8K citations

Lipid Analysis, Hyperlipidemia, Thrombosis +18

Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial

Carlos Abraira, John A. Colwell, Frank Q. Nuttall et al. · Diabetes Care · 1995 · 357 citations

Increased platelet thromboxane synthesis in diabetes mellitus.

Perry V. Halushka, Richard C. Rogers, C B Loadholt et al. · PubMed · 1981 · 257 citations

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

Michael Pignone, Mark J. Alberts, John A. Colwell et al. · Diabetes Care · 2010 · 241 citations · Full text

Hypertension, Coronary Artery Disease, Acute Myocardial Infarction +20